Effects of anti-inflammatory treatment on inflammatory infiltrate and ventilation parameters in patients with moderate COPD

A. Chcialowski, W. Lubinski, I. Toczyska, L. Dudko, C. Jochymski, W. Kozlowski (Warsaw, Poland)

Source: Annual Congress 2007 - Unravelling molecular mysteries of COPD
Session: Unravelling molecular mysteries of COPD
Session type: Thematic Poster Session
Number: 927
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Chcialowski, W. Lubinski, I. Toczyska, L. Dudko, C. Jochymski, W. Kozlowski (Warsaw, Poland). Effects of anti-inflammatory treatment on inflammatory infiltrate and ventilation parameters in patients with moderate COPD. Eur Respir J 2007; 30: Suppl. 51, 927

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The influence of statin supplementation on inflammatory markers in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015

Rosuvastatin influence on inflammatory and anti-inflammatory cytokines in blood in patients with chronic obstructive pulmonary disease
Source: International Congress 2017 – COPD management
Year: 2017


Effect of one moderate or mild exacerbation on lung function and serum inflammatory markers in ex smokers patients with COPD
Source: Annual Congress 2009 - Cellular-tissue modifications and functional evaluation in COPD patients
Year: 2009


The effect of statin therapy in patients with chronic obstructive airway disease
Source: International Congress 2015 – COPD: notable points
Year: 2015


Effects of formoterol-budesonide combination on residual eosinophilic inflammation in distal airway of patients with well-controlled moderate asthma
Source: Annual Congress 2011 - Asthma management and response
Year: 2011

Effects of dexamethasone and anti-inflammatory drugs on inflammatory cytokines from bronchial epithelial cells of COPD patients
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015


Impact of treatment on a number of BALF inflammatory cells and cytokines concentrations in patients with moderate COPD
Source: Annual Congress 2008 - COPD: from bench to bedside
Year: 2008


The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013


Outcome of COPD exacerbations treated with and without oral steroids in relation to airway and systemic inflammation
Source: Eur Respir J 2005; 26: Suppl. 49, 283s
Year: 2005

Rosuvastatin effects on systemic inflammation, oxidative stress and antioxidants in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016


The interrelationship of the inflammatory markers in blood and sputum of stable COPD patients before and after treatment with inhaled steroids and N-acetylcysteine
Source: Eur Respir J 2003; 22: Suppl. 45, 281s
Year: 2003

Macrolide effects on the prevention of COPD exacerbations
Source: Eur Respir J 2012; 40: 485-494
Year: 2012



Effects of pulmonary rehabilitation on systemic inflammation in patients with advanced COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 721s
Year: 2005

Effect of azithromycin treatment on inflammation in COPD patients
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019


Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment
Source: Eur Respir J 2006; 27: 964-971
Year: 2006



Effect of oral N-acetylcysteine treatment on systemic inflammatory status in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 716s
Year: 2005

Effects of inhaled corticosteroids on airway inflammations of different types in patients with chronic obstructive pulmonary disease or asthma in stable phase
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009


Effects of steroid treatment on hemodynamic and haemostatic parameters in COPD exacerbation
Source: Eur Respir J 2005; 26: Suppl. 49, 298s
Year: 2005

Effects of pulmonary rehabilitation on systemic and pulmonary inflammation in COPD patients
Source: Annual Congress 2010 - Exercise in COPD
Year: 2010


Effect of aerobic training on airway inflammation and symptoms in asthmatic patients maintaining corticosteroid treatment
Source: Annual Congress 2007 - Effects of training in rehabilitation
Year: 2007